3-苯氧基环丁烷羧酸 | 1263284-46-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 3-苯氧基环丁烷羧酸
• 英文名称: 3-phenoxycyclobutanecarboxylic acid
• 英文别名: 3-phenoxycyclobutane-1-carboxylic acid
• CAS: 1263284-46-3
• 化学式: C₁₁H₁₂O₃
• 分子量: 192.214
• InChiKey: UHQWCVMRTDYEKK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-苯氧基环丁烷羧酸 、 4-amino-N-hydroxy-6-[methyl(phenyl)amino]-1,3,5-triazine-2-carboximidamide 以42%的产率得到2-N-methyl-6-[5-(3-phenoxycyclobutyl)-1,2,4-oxadiazol-3-yl]-2-N-phenyl-1,3,5-triazine-2,4-diamine
  参考文献：
  名称：

  [EN] TRIAZINE-OXADIAZOLES
  [FR] TRIAZINE-OXADIAZOLES

  摘要：

  这项发明涉及公式（I）的新衍生物，其中取代基如规范中所定义；制备这种衍生物的方法；包括这种衍生物的药物组合物；将这种衍生物用作药物；将这种衍生物用于治疗慢性疼痛。

  公开号：

  WO2012035023A1
• 作为产物：
  描述：

  benzyl 3-phenoxycyclobutane-1-carboxylate 在 palladium 10% on activated carbon 氢气 作用下， 以 乙醇 为溶剂， 反应 2.0h， 以95%的产率得到3-苯氧基环丁烷羧酸
  参考文献：
  名称：

  [EN] TRIAZINE-OXADIAZOLES
  [FR] TRIAZINE-OXADIAZOLES

  摘要：

  这项发明涉及公式（I）的新衍生物，其中取代基如规范中所定义；制备这种衍生物的方法；包括这种衍生物的药物组合物；将这种衍生物用作药物；将这种衍生物用于治疗慢性疼痛。

  公开号：

  WO2012035023A1

文献信息

• [EN] NOVEL TRICYCLIC COMPOUNDS AS INHIBITORS OF MUTANT IDH ENZYMES<br/>[FR] COMPOSÉS TRICYCLIQUES INNOVANTS SERVANT D'INHIBITEURS D'ENZYMES IDH MUTANTES
  申请人：MERCK SHARP & DOHME

  公开号：WO2016089797A1

  公开（公告）日：2016-06-09

  The present invention is directed to tricyclic compounds of formula (I) which are inhibitors of one or more mutant IDH enzymes: (I). The present invention is also directed to uses of the tricyclic compounds described herein in the potential treatment or prevention of cancers in which one or more mutant IDH enzymes are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such cancers.

  本发明涉及式(I)的三环化合物，该化合物是野生型异柠檬酸脱氢酶（IDH）抑制剂：(I)。本发明还涉及将此处描述的三环化合物用于潜在治疗或预防涉及一个或多个突变IDH酶的癌症。本发明还涉及包含这些化合物的组合物。本发明还涉及将这些组合物用于潜在预防或治疗此类癌症。
• Triazine-oxadiazoles
  申请人：BARKER Oliver

  公开号：US20140051676A1

  公开（公告）日：2014-02-20

  The invention relates to new derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of chronic pain.

  该发明涉及公式(I)的新衍生物，其中取代基如规范中所定义；制备这种衍生物的方法；包含这种衍生物的药物组合物；这种衍生物作为药物；这种衍生物用于治疗慢性疼痛。
• Tricyclic compounds as inhibitors of mutant IDH enzymes
  申请人：Fischer Christian

  公开号：US10442819B2

  公开（公告）日：2019-10-15

  The present invention is directed to tricyclic compounds of formula (I) which are inhibitors of one or more mutant IDH enzymes: (I). The present invention is also directed to uses of the tricyclic compounds described herein in the potential treatment or prevention of cancers in which one or more mutant IDH enzymes are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such cancers.

  本发明涉及式(I)的三环化合物，它是一种或多种突变 IDH 酶的抑制剂：(I)。本发明还涉及本文所述三环化合物在潜在治疗或预防涉及一种或多种突变 IDH 酶的癌症中的用途。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在预防或治疗此类癌症中的用途。
• TRIAZINE-OXADIAZOLES
  申请人：Novartis AG

  公开号：EP2616465A1

  公开（公告）日：2013-07-24
• NOVEL TRICYCLIC COMPOUNDS AS INHIBITORS OF MUTANT IDH ENZYMES
  申请人：Merck Sharp & Dohme Corp.

  公开号：EP3226688A1

  公开（公告）日：2017-10-11